Staining assays of major cancer signaling pathways can be
offered. Assessment for active/total b-catenin, pAkt (Thr308) / total Akt, pERK
(Thr202, Tyr201) / total ERK1 / 2, p-SRC (Tyr 527 inactivating) / pSRC (Tyr 416
activating) / total SRC, cytoskeletal actin / tubulin staining, and multiplex
IF staining are currently available.
Immunofluorescence staining of Src and